相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M. C. Fargnoli et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
E. Nettis et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Lieneke F. M. Ariens et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
Firas Constantin Kreeshan et al.
DERMATOLOGY AND THERAPY (2021)
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study
Christine E. Jo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
J. C. Armario-Hita et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Atopic dermatitis of the adult
M. Hello et al.
REVUE DE MEDECINE INTERNE (2016)